Creatine phosphokinase activity in dysgenic (mdg/mdg) mouse muscle
Related Experiment Video
Updated: Oct 24, 2026
Myo-mechanical Analysis of Isolated Skeletal Muscle
Published on: February 22, 2011
Abstract:
The specific activity of creatine phosphokinase (CPK) was measured in the muscle of mdg/mdg and control embryos of 14-18 days' gestation. CPK specific activity values were similar in mutant and normal embryos at the earliest stages examined (14-15 days). However, after 15 1/2 days, the specific activity of the enzyme in the mdg/mdg embryos was approximately 50% lower than in the controls. The dysgenic and normal muscle extracts exhibited comparable stability after storage at -85 C. CPK activity levels in the muscle of adult heterozygotes (+/mdg) and wild-type (+/+) controls were found to be statistically identical. The findings suggest that the mdg mutation does not have a primary or direct effect on CPK activity.
Insights
Creatine phosphokinase (CPK) activity decreases in mdg/mdg embryos after 15.5 days of gestation. However, this mutation does not appear to directly impact CPK levels in adult muscle tissue.
Area of Science:
- Biochemistry
- Developmental Biology
- Genetics
Background:
- Creatine phosphokinase (CPK) is a crucial enzyme in energy metabolism, particularly in muscle tissue.
- The mdg mutation is a genetic alteration affecting embryonic development.
Purpose of the Study:
- To investigate the specific activity of CPK in the muscle of mdg/mdg mutant embryos compared to controls.
- To determine if the mdg mutation has a direct effect on CPK activity during embryonic development and in adult heterozygotes.
Main Methods:
- Measurement of CPK specific activity in muscle tissue from 14-18 days' gestation embryos.
- Comparison of CPK activity between mdg/mdg mutant embryos and wild-type controls.
- Assessment of CPK activity in adult heterozygotes (+/mdg) and wild-type (+/+) controls.
Main Results:
- CPK specific activity was similar in mutant and normal embryos at 14-15 days of gestation.
- After 15.5 days, mdg/mdg embryos showed approximately 50% lower CPK specific activity than controls.
- CPK activity levels in adult heterozygotes were statistically identical to wild-type controls.
Conclusions:
- The mdg mutation leads to a significant reduction in CPK specific activity in late-stage embryonic muscle.
- The observed decrease in CPK activity during embryogenesis does not appear to be a primary or direct effect of the mdg mutation.
- CPK activity is not affected in the muscle of adult mdg heterozygotes, suggesting developmental stage-specific or indirect effects.
